Skip to Content
Merck
CN

T8900

Thiacetazone

Synonym(s):

4′-Formylacetanilide thiosemicarbazone

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Empirical Formula (Hill Notation):
C10H12N4OS
CAS Number:
Molecular Weight:
236.29
UNSPSC Code:
51101500
PubChem Substance ID:
EC Number:
203-170-6
MDL number:
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


SMILES string

[H]\C(=N/NC(N)=S)c1ccc(NC(C)=O)cc1



pictograms

Exclamation mark

signalword

Warning

hcodes

Hazard Classifications

Acute Tox. 4 Oral

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Gloves

Regulatory Information

新产品

This item has



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Geoffrey D Coxon et al.
PloS one, 8(1), e53162-e53162 (2013-01-10)
Defining the pharmacological target(s) of currently used drugs and developing new analogues with greater potency are both important aspects of the search for agents that are effective against drug-sensitive and drug-resistant Mycobacterium tuberculosis. Thiacetazone (TAC) is an anti-tubercular drug that
Farhad Mostafavi Shahab et al.
Archives of pharmacal research, 32(10), 1453-1460 (2009-11-10)
KBF-611 is a new thiosemicarbazone derivative which has demonstrated significant antituberculosis effect. A sensitive and specific HPLC method was established and validated for the determination of KBF-611 and its deacetylated metabolite (KM) in mouse and rabbit plasma. Chromatographic separation was
Masako Wada et al.
Kekkaku : [Tuberculosis], 82(1), 33-37 (2007-02-22)
A 30 years-old-male was referred to our hospital for surgical treatment of multidrug-resistant tuberculosis in April 1998, three years after diagnosis of tuberculosis. All first-line anti-tuberculosis drugs and second-line anti-tuberculosis drugs were resistant on drug susceptibility tests by Ogawa medium.